Newsletter | June 1, 2023

06.01.23 -- What You Should Expect From A High-Functioning CDMO

Sponsor

Featured Editorial

What You Should Expect From A High-Functioning CDMO
		By Mark Roache, VP of Cell and Gene Therapies for Quality Executive Partners, Inc. and president of BioQPartners, Inc., and Sarah Boynton, owner of Biopharma Staffing and Consulting Solutions, LLC In part one of a two-part series, the authors detail whether to make or buy and how to work effectively with a CDMO.

A Summary Of Cell & Gene Therapies Manufacturing Outlook Report: 2023 Edition
By Erin Harris, Editor-In-Chief, Cell & Gene Industry Standard Research (ISR) recently released Cell & Gene Therapies Manufacturing Outlook (2nd edition), and just like its predecessor, it’s chock full of valuable data. Here's a summary of their findings.

Industry Insights

Propelling Gene Therapies From Lab To Clinic

Article | By Lan Ly, Ph.D., FUJIFILM Diosynth Biotechnologies

The lack of established processes and analytical methods often complicates the path to commercialization. Many companies are turning to CDMOs that can help optimize biomanufacturing processes.

Optimizing Extracellular Vesicle/Exosome Upstream Process Development

Article | By Stephen Lenzini, RoosterBio

In this blog, discover feasible strategies to maximize the number of hMSC-EVs generated by the upstream process and how to make well-engineered hMSC-EVs a thriving therapeutic modality.

Why Is E&L Testing Important For Single-Use Connectors?

White Paper | CPC

A critical issue when transitioning from stainless steel to plastic equipment is the presence of extractables and leachables (E&L). BPOG testing on single-use connectors mitigates the risks.

Translatability Of T Cell Reagents For T Cell Activation Process Development

Application Note | Miltenyi Biotec

Process development is riddled with challenges — and one major obstacle involves finding reagents that can achieve an equivalent physiological response when moving from research to manufacturing.

Radiance Label-Free Monitoring Of AAV Transfection In HEK293 Cells

Application Note | Catalent

Improve the characterization of cell-based AAV transfection and production, increase the efficiency and accuracy of both processes, and shorten development time.

2000L Scale GMP AAV Manufacturing Process Guidelines Using FectoVIR-AAV

Infographic | Polyplus

Learn more about manufacturing process guidelines from seed train to quality control/analytics for batch release.

Maximize Your Gene Therapy Process With Genetic Analysis

Infographic | Applied Biosystems by Thermo Fisher Scientific, qPCR

Propel your gene therapy research to the forefront of discovery by incorporating genetic analysis into your investigations at any phase of the development process.

Sponsor